DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
49. 全身性エリテマトーデス
Systemic lupus erythematosus
Clinical trials
/
Disease details
臨床試験数
:
993
/
薬物数
:
702
- (
DrugBank
:
184
) /
標的遺伝子数
:
116
-
標的パスウェイ数
:
200
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT01845740
(
ClinicalTrials.gov
)
January 2007
17/4/2013
Phase Ib Study of SC
Milatuzumab
in SLE
A Phase Ib Study of
Milatuzumab
Administered Subcutaneously in Patients With Active Systemic Lupus Erythematosus (SLE)
A Phase Ib Study of
Milatuzumab
Administered Subcutaneously in Patients With Active Systemic Lupus Er ...
Lupus Erythematosus, Cutaneous;Lupus Erythematosus, Discoid;Lupus Erythematosus, Systemic;Lupus Vasculitis, Central Nervous System;Lupus Nephritis
Lupus Erythematosus, Cutaneous;Lupus Erythematosus, Discoid;Lupus Erythematosus, Systemic;Lupus Vasc ...
Drug:
milatuzumab
;Drug: Placebo
Gilead Sciences
United States Department of Defense
Completed
18 Years
N/A
All
22
Phase 1
United States